Sail Biomedicines

Developing programmable medicines using circular RNA and nanoparticle platforms.

BiotechnologyPharmaceuticals sail.bio ↗

Company facts

Founded
2023
Employees
117
Headquarters
United States
Type
Private
Funding
Corporate Round · $700M · 2023
Subsidiaries
Senda Biosciences, Laronde